Treating Gulf War Illness with Novel Anti-Inflammatories: A Screening of Botanical Microglia Modulators

Abstract

Since the last annual report, we have continued with periodic advertising, recruitment, participant screening, participant enrollment, and the study protocol. All start up subtasks have been completed. The study treatment compounds have been purchased, and the blinded capsules have been created and prepared into randomized lines. To date, 222 potential participants have filled out the online screening questionnaire, 129 of those have been screened by telephone, and 34 participants have enrolled into the study, and 3 have re-enrolled. 5 other potential participants have been identified as meeting initial eligibility requirements, and we expect to meet our end goal number during the next reporting period. We have been approved to enroll participants with diabetes.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2017
Accession Number
AD1043613

Entities

People

  • Emily K Donovan
  • Jarred Younger
  • Tammie Quinn

Organizations

  • University of Alabama at Birmingham

Tags

DTIC Thesaurus Topics

  • Abstracts
  • Biomedical Research
  • Chronic Fatigue Syndrome
  • Department Of Defense
  • Diseases And Disorders
  • Electronic Mail
  • Information Operations
  • Modulators
  • Neuroglia
  • Patent Applications
  • Persian Gulf Syndrome
  • Professional Development
  • Questionnaires
  • Standards
  • Technology Transfer
  • Training
  • Universities

Readers

  • Clinical Trial Research.
  • Gulf War Illness and Chronic Multisymptom Illness in Veterans.